STERLING, Va., June 11, 2026 — Euclid Vision Corporation, a global leader in advanced orthokeratology and specialty contact lenses, today announced that Be Free Day toric lenses have received FDA clearance¹ and will be available in the United States in fall 2026, adding a daily disposable multifocal-toric lens option for patients with myopia and astigmatism.
With clinically significant astigmatism affecting approximately 25% of patients with myopia, the addition of a toric lens option addresses a common fitting need among patients who require astigmatic correction.²
“The Be Free Day spherical lens has been a tremendous success in my practice since it launched. With a toric lens option, it gives me a better way to support my patients with myopia and astigmatism—while keeping the fitting process simple,” said Dr. Brianna Rhue, OD, FAAO, a clinical innovator in myopia management and early adopter of Be Free Day lenses in her practice.
Built with technology from the Brien Holden Vision Institute (BHVI), the new multifocal-toric lens option combines the optical design and properties of Be Free Day spherical lenses with toric correction for patients with astigmatism. In patient-reported outcomes, Be Free Day lenses have received strong satisfaction ratings for vision, comfort and overall wear experience.³
“We are excited about adding a novel toric lens to our daily disposable lens franchise, giving eye care professionals science-driven options that fit into real-world clinical workflows,” said Linda Chang, CEO of Euclid Vision. “Be Free Day toric lenses broaden our support of practitioners seeking flexible lens options for modern myopia care.”
Eyecare practitioners looking to familiarize themselves with Be Free Day lenses ahead of the upcoming toric lens launch can request their spherical trial kits at EuclidLenses.com/BeFreeDay.
References
¹Be Free Day (Toufilcon B) Daily Disposable Soft (Hydrophilic) contact lenses with multifocal toric designs are FDA cleared for daily wear for the correction of refractive ametropia (myopia and hyperopia) and/or presbyopia in aphakic and/or non-aphakic persons with non-diseased eyes in powers from +6.00 to −12.25 diopters and with non-diseased eyes who may require a reading addition of +0.25D to +3.00D and have −3.50 diopters of astigmatism or less.
²Market Scope. 2026 Myopia Management Market Report: Global Analysis for 2025 to 2031. Market Scope, LLC; May 2026. Available at: market-scope.com
³Bullimore M, Díaz-Gómez S, Burgos-Martínez M, Razquín-García A, Velasco de la Fuente M, Durán-Prieto E, et al. Performance comparison of two daily disposable myopia care contact lenses: stepped anti-myopia vs dual-focus. [Poster] Presented at: NCC; March 2026; Eindhoven, The Netherlands. Study conducted in 40 patients aged 9–16 years over 15 days of use.
